Article Text

PDF
GW24-e2244 Ginsenosides-Rbl improves adriamycin-induced heart failure by adjusting connexin 43
  1. Li Zhan-quan
  1. The People’s Hospital of LiaoNing Province

Abstract

Objectives On the basis of adriamycin (Adr)-induced heart failure (HF), the present study elucidated whether the effect of Ginsenosides-Rbl (Gs-Rb1), improving cardiac function, was performed by connexin 43 (CX43) and other mechanisms.

Methods Rats with Adr-induced HF were randomly divided into Adr group (n = 15) and Gs-Rb1 group (n = 17), and the health age-matched rat was as control (n = 15); In addition, cardiomyocytes was randomly divided into Adr group, Gs-Rb1 group and control group, in vitro. After the above intervention being performed, echoeardiography or apoptosis ratio (AR) was analysed, respectively. CX43, p21-activated kinase 1 (PAK2) and protein phosphatase type 2A (PP2A) was assayed by western bolt or Rt-PCR, respectively.

Results 1. Gs-Rbl significantly improved LVEF (in vivo), markedly left ventricular weight index (in vivo) and significantly inhibited cell apoptosis (in vitro), all of which were induced by Adr; 2. Both mRNA and protein of CX43, being significantly decreased by Adr, were significantly up-regulated by Gs-Rbl, in vivo and in vitro; 3. There was no significance for PAK1 protein between Adr group and control group, which was markedly increased by Gs-Rbl, in vivo and in vitro; 4. PP2A protein was significantly up-regulated in Gs-Rbl group than in Adr group and in Adr group than in control group, in vivo and in vitro.

Conclusions The effect of Gs-Rb1, improving HF and inhibiting cell apoptosis, was partly performed through adjusting CX43 at least, which may be mediated by PAK1-PP2A.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.